AzTrials
AzTrials

Chest PainTRUENCT01836211

High-Sensitivity Troponin T and Coronary Computed Tomography Angiography for Rapid Diagnosis of Emergency Chest Pain

A study testing Fast strategy in people with Chest Pain and Acute Coronary Syndrome, run by Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau at 1 site in Spain.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

The purpose of this study is to determine the efficacy and safety of an evaluation strategy based on utilization of high sensitivity cardiac troponin T (hscTnT), followed by coronary computed tomography angiography (CCTA) in patients with low-intermediate risk chest pain consistent with a possible acute coronary… Read more about this study

Who is it for?
Ages 18 to 90 years
Conditions the study is for
Chest Pain, Acute Coronary Syndrome
What is being tested?
Fast strategy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
101 participants
Where
1 siteSpain
Study dates
Sep 2011to Jun 2013
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 90 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients with chest pain consistent with possible acute coronary syndrome.
  • Age > 18 years.
  • Informed consent.

Who cannot join

  • Previous history of coronary artery disease.
  • Electrocardiogram diagnostic or suggestive of myocardial ischemia.
  • Condition other than coronary artery disease as cause of an imbalance between myocardial oxygen supply and/or demand (eg. anemia, fever, arrhythmias).
  • Chronic kidney disease (GFR <30 mL/min/1,73 m2).
  • Iodine contrast allergy.
  • Incapability to perform treadmill stress test.
  • Barthel activity of daily living scale index < 100.

Trial locations and contacts

1 site in 1 country.

Spain1 site
  • Hospital de la Santa Cruz y San Pablo

    Barcelona, Barcelona, 08025

Other trials in Spain

About this study

Official title: High-Sensitivity Troponin T and Coronary Computed Tomography Angiography for Rapid Diagnosis of Emergency Chest Pain: a Randomized Controlled Study

  • The purpose of this study is to determine the efficacy and safety of an evaluation strategy based on utilization of high sensitivity cardiac troponin T (hscTnT), followed by coronary computed tomography angiography (CCTA) in patients with low-intermediate risk chest pain consistent with a possible acute coronary syndrome compared to a standard of care (SOC) strategy.
  • Unicentric, randomized, controlled, open label clinical trial that will compare a fast strategy (hscTnT followed by CCTA) with a SOC strategy (serial ECG and cardiac biomarkers followed by stress/rest imaging study).
Being tested
Fast strategy, Standard of care strategy
Keywords
Chest pain, Acute coronary syndrome, Cardiac biomarkers, Computed coronary tomography angiography, Emergency department
Medical subject headings
Chest Pain, Acute Coronary Syndrome, Emergencies

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Fast strategyOther

    High sensitivity troponin T followed by computed coronary tomography angiography

  • Standard of care strategyOther

    Standard of care strategy: serial electrocardiograms and cardiac biomarkers followed by stress/rest cardiac imaging study

Study groups in NCT01836211
Study groupRoleWhat they receive
Fast strategyExperimentalHigh sensitivity cardiac troponin T followed by computed coronary tomography angiography
Receives: Other: Fast strategy
Standard of care strategyActive comparatorStandard of care strategy based on serial electrocardiograms and cardiac biomarkers followed by stress/rest cardiac imaging study
Receives: Other: Standard of care strategy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. All cause mortality, new myocardial infarction, new unstable angina, new heart failure, new hospital admission, new consult to the Emergency Department

    Composite end-point.

    Measured: 1 month after index event

Secondary outcomes (5)
  1. All cause mortality

    Measured: 1 month

  2. Myocardial infarction

    Measured: 1 month

  3. Unstable angina

    Measured: 1 month

  4. Heart Failure

    Measured: 1 month

  5. Hospital admission

    New cardiovascular hospital admission

    Measured: 1 month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Apr 2013 (estimated)
  2. Study startSep 2011
  3. Primary completionApr 2013 (estimated)
  4. Study completionJun 2013 (estimated)

Why it stopped: low recruitment

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
101 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01836211
Sponsor's protocol ID
IIBSP-DIA-2010-18
Acronym
TRUE
Status last verified
Apr 2013
First submitted
23 Nov 2012
Last updated
19 Apr 2013
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

A study testing Fast strategy in people with Chest Pain and Acute Coronary Syndrome, run by Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 19 Apr 2013. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: low recruitment). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

All cause mortality, new myocardial infarction, new unstable angina, new heart failure, new hospital admission, new consult to the Emergency Department (time frame: 1 month after index event). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Apr 2013.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in